Ocumension Therapeutics (HKG:1477)

Ocumension Therapeutics Statistics

Total Valuation

HKG:1477 has a market cap or net worth of HKD 5.63 billion. The enterprise value is 5.08 billion.

Market Cap	5.63B
Enterprise Value	5.08B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1477 has 815.38 million shares outstanding. The number of shares has increased by 14.22% in one year.

Current Share Class	815.38M
Shares Outstanding	815.38M
Shares Change (YoY)	+14.22%
Shares Change (QoQ)	+11.42%
Owned by Insiders (%)	16.43%
Owned by Institutions (%)	7.77%
Float	297.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.44
PB Ratio	1.41
P/TBV Ratio	4.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.61
EV / Sales	8.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.78

Financial Position

The company has a current ratio of 5.29, with a Debt / Equity ratio of 0.02.

Current Ratio	5.29
Quick Ratio	4.86
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.43
Interest Coverage	-241.86

Financial Efficiency

Return on equity (ROE) is -7.76% and return on invested capital (ROIC) is -5.38%.

Return on Equity (ROE)	-7.76%
Return on Assets (ROA)	-5.07%
Return on Invested Capital (ROIC)	-5.38%
Return on Capital Employed (ROCE)	-7.50%
Weighted Average Cost of Capital (WACC)	6.98%
Revenue Per Employee	1.18M
Profits Per Employee	-540,845
Employee Count	505
Asset Turnover	0.16
Inventory Turnover	4.30

Taxes

In the past 12 months, HKG:1477 has paid 1.14 million in taxes.

Income Tax	1.14M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +75.88% in the last 52 weeks. The beta is 0.51, so HKG:1477's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	+75.88%
50-Day Moving Average	7.63
200-Day Moving Average	8.47
Relative Strength Index (RSI)	40.86
Average Volume (20 Days)	1,111,619

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1477 had revenue of HKD 595.79 million and -273.13 million in losses. Loss per share was -0.36.

Revenue	595.79M
Gross Profit	253.68M
Operating Income	-307.43M
Pretax Income	-271.98M
Net Income	-273.13M
EBITDA	-184.31M
EBIT	-307.43M
Loss Per Share	-0.36

Balance Sheet

The company has 633.66 million in cash and 91.19 million in debt, with a net cash position of 542.46 million or 0.67 per share.

Cash & Cash Equivalents	633.66M
Total Debt	91.19M
Net Cash	542.46M
Net Cash Per Share	0.67
Equity (Book Value)	4.00B
Book Value Per Share	4.92
Working Capital	726.52M

Cash Flow

In the last 12 months, operating cash flow was -176.33 million and capital expenditures -37.42 million, giving a free cash flow of -213.75 million.

Operating Cash Flow	-176.33M
Capital Expenditures	-37.42M
Free Cash Flow	-213.75M
FCF Per Share	-0.26

Margins

Gross margin is 42.58%, with operating and profit margins of -51.60% and -45.84%.

Gross Margin	42.58%
Operating Margin	-51.60%
Pretax Margin	-45.65%
Profit Margin	-45.84%
EBITDA Margin	-30.94%
EBIT Margin	-51.60%
FCF Margin	n/a

Dividends & Yields

HKG:1477 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.22%
Shareholder Yield	-14.22%
Earnings Yield	-4.85%
FCF Yield	-3.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1477 has an Altman Z-Score of 8.45 and a Piotroski F-Score of 2.

Altman Z-Score	8.45
Piotroski F-Score	2